您的位置: 首页 > 农业专利 > 详情页

CYCLIC NTCP-TARGETING PEPTIDES AND THEIR USES AS ENTRY INHIBITORS
专利权人:
发明人:
申请号:
EP16822406.1
公开号:
EP3389691A1
申请日:
2016.12.15
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
The derivative peptide hepatitis type B virus (HBV) that these assume the present invention relates to cyclic n nitroso compound TCP targets peptide. The present invention also relates to pharmaceutical compositions, and it includes at least one cyclic peptide. The invention additionally relates to the pharmaceutical compositions of the cyclic peptide medical application, such as in diagnosis, prevention or treatment hepatopathy or condition, and/or inhibit HBV and/or HDV infection. The invention additionally relates to diagnostic method, prevents or treat hepatopathy or condition and/or inhibit HBV and/or HDV infection.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充